Evaluating the Potential Bioactivity of a Novel Compound ER1626

Open Access

Peer-reviewed

Research Article

Lijun Wang ,

Contributed equally to this work with: Lijun Wang, Yanyan Zeng

Affiliation Nanjing Medical University, Affiliated Nanjing Brain Hospital, Nanjing, China
⨯
Yanyan Zeng ,

Contributed equally to this work with: Lijun Wang, Yanyan Zeng

Affiliation Nanjing Medical University, Affiliated Nanjing Brain Hospital, Nanjing, China
⨯
Tianling Wang,

Affiliation Department of Pharmaceutical Chemistry, China Pharmaceutical University, Nanjing, China
⨯
Hongyi Liu,

Affiliation Nanjing Medical University, Affiliated Nanjing Brain Hospital, Nanjing, China
⨯
Hong Xiao ,

* E-mail: xhnkyy123@163.com (H. Xiao); cpuxianghua@sina.com (H. Xiang)

Affiliation Nanjing Medical University, Affiliated Nanjing Brain Hospital, Nanjing, China
⨯
Hua Xiang

* E-mail: xhnkyy123@163.com (H. Xiao); cpuxianghua@sina.com (H. Xiang)

Affiliation Department of Pharmaceutical Chemistry, China Pharmaceutical University, Nanjing, China
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Estrogens
Is the Subject Area "Estrogens" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Cell migration
Is the Subject Area "Cell migration" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.